{"rows":[{"id":1172,"title":"Acute Adverse Effects of Therapeutic Doses of Psilocybin: A Systematic Review and Meta-Analysis.","authors":"Yerubandi A, Thomas JE, Bhuiya NMMA, Harrington C, Villa Zapata L, Caballero J","journal":"JAMA network open","publication_date":"2024-04-01","publication_year":2024,"doi":"10.1001/jamanetworkopen.2024.5960","pubmed_id":"38598236","openalex_id":"https://openalex.org/W4394693583","source_url":"https://pubmed.ncbi.nlm.nih.gov/38598236/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Headache / Migraine,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Safety","study_type":"Meta-Analysis","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:09","bibtex":null,"source_record_id":"PMID:38598236","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/38598236/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:38598236","source_url":"https://pubmed.ncbi.nlm.nih.gov/38598236/","doi":"10.1001/jamanetworkopen.2024.5960","pmid":"38598236","publication_date":"2024-04-01","importer_version":"2.1.3","text_redistributed":false}},{"id":936,"title":"Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic: A Randomized Clinical Trial.","authors":"Back AL, Freeman-Young TK, Morgan L, Sethi T, Baker KK, Myers S, McGregor BA, Harvey K, Tai M, Kollefrath A, Thomas BJ, Sorta D, Kaelen M, Kelmendi B, Gooley TA","journal":"JAMA network open","publication_date":"2024-12-02","publication_year":2024,"doi":"10.1001/jamanetworkopen.2024.49026","pubmed_id":"39636638","openalex_id":"https://openalex.org/W4405031949","source_url":"https://pubmed.ncbi.nlm.nih.gov/39636638/","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Clinical Trial,Healthcare Workers","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:05","bibtex":null,"source_record_id":"PMID:39636638","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39636638/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39636638","source_url":"https://pubmed.ncbi.nlm.nih.gov/39636638/","doi":"10.1001/jamanetworkopen.2024.49026","pmid":"39636638","publication_date":"2024-12-02","importer_version":"2.1.3","text_redistributed":false}},{"id":754,"title":"Psilocybin Dispensaries and Online Health Claims in Canada.","authors":"Matsukubo J, Dickson S, Xiao J, Friesen EL, Solmi M, Fiedorowicz JG, Fischer B, Myran DT","journal":"JAMA network open","publication_date":"2025-04-01","publication_year":2025,"doi":"10.1001/jamanetworkopen.2025.2853","pubmed_id":"40168023","openalex_id":"https://openalex.org/W4409086968","source_url":"https://pubmed.ncbi.nlm.nih.gov/40168023/","substance_tags":"psilocybin","topic_tags":"Anxiety,Microdosing,Clinical Trial","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:00","bibtex":null,"source_record_id":"PMID:40168023","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40168023/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40168023","source_url":"https://pubmed.ncbi.nlm.nih.gov/40168023/","doi":"10.1001/jamanetworkopen.2025.2853","pmid":"40168023","publication_date":"2025-04-01","importer_version":"2.1.3","text_redistributed":false}},{"id":753,"title":"Psilocybin Dispensaries and Advertising-Buyer Beware.","authors":"Hutson PR","journal":"JAMA network open","publication_date":"2025-04-01","publication_year":2025,"doi":"10.1001/jamanetworkopen.2025.2858","pubmed_id":"40168028","openalex_id":"https://openalex.org/W4409045029","source_url":"https://pubmed.ncbi.nlm.nih.gov/40168028/","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:00","bibtex":null,"source_record_id":"PMID:40168028","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40168028","source_url":"https://pubmed.ncbi.nlm.nih.gov/40168028/","doi":"10.1001/jamanetworkopen.2025.2858","pmid":"40168028","publication_date":"2025-04-01","importer_version":"2.1.3","text_redistributed":false}},{"id":618,"title":"Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis.","authors":"Hieronymus F, López E, Werin Sjögren H, Lundberg J","journal":"JAMA network open","publication_date":"2025-07-01","publication_year":2025,"doi":"10.1001/jamanetworkopen.2025.24119","pubmed_id":"40736734","openalex_id":"https://openalex.org/W4412738512","source_url":"https://pubmed.ncbi.nlm.nih.gov/40736734/","substance_tags":"psilocybin","topic_tags":"Depression,Receptor Pharmacology,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression","study_type":"Meta-Analysis","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:58","bibtex":null,"source_record_id":"PMID:40736734","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40736734/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40736734","source_url":"https://pubmed.ncbi.nlm.nih.gov/40736734/","doi":"10.1001/jamanetworkopen.2025.24119","pmid":"40736734","publication_date":"2025-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":526,"title":"Active Constituents of Psilocybin Mushroom Edibles.","authors":"van Breemen RB, Simchuk D, Fritzsche B, Huson D, Kuzdzal SA, Ferguson J","journal":"JAMA network open","publication_date":"2025-09-02","publication_year":2025,"doi":"10.1001/jamanetworkopen.2025.31345","pubmed_id":"40932719","openalex_id":"https://openalex.org/W4414123038","source_url":"https://pubmed.ncbi.nlm.nih.gov/40932719/","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:56","bibtex":null,"source_record_id":"PMID:40932719","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40932719/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40932719","source_url":"https://pubmed.ncbi.nlm.nih.gov/40932719/","doi":"10.1001/jamanetworkopen.2025.31345","pmid":"40932719","publication_date":"2025-09-02","importer_version":"2.1.3","text_redistributed":false}},{"id":335,"title":"Reported Safety Practices of Publicly Advertised Psychedelic Retreats.","authors":"McGuire AL, Neitzke-Spruill L, Robinson JO, Beit CS, Singh N, Mathai DS, Averill LA","journal":"JAMA network open","publication_date":"2026-01-02","publication_year":2026,"doi":"10.1001/jamanetworkopen.2025.52505","pubmed_id":"41499117","openalex_id":"https://openalex.org/W7118708255","source_url":"https://pubmed.ncbi.nlm.nih.gov/41499117/","substance_tags":"psilocybin","topic_tags":"Addiction,Safety","study_type":"Qualitative Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:53","bibtex":null,"source_record_id":"PMID:41499117","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41499117/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41499117","source_url":"https://pubmed.ncbi.nlm.nih.gov/41499117/","doi":"10.1001/jamanetworkopen.2025.52505","pmid":"41499117","publication_date":"2026-01-02","importer_version":"2.1.3","text_redistributed":false}},{"id":334,"title":"Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.","authors":"Florineth GA, Klima I, Boeker AL, Catzeflis P, Wopfner A, Denier N, Bracht T, Adorjan K, Pfammatter M, Müller F, Soravia LM","journal":"JAMA network open","publication_date":"2026-01-02","publication_year":2026,"doi":"10.1001/jamanetworkopen.2025.54843","pubmed_id":"41563753","openalex_id":"https://openalex.org/W7125277592","source_url":"https://pubmed.ncbi.nlm.nih.gov/41563753/","substance_tags":"psilocybin","topic_tags":"Depression,Microdosing,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Case Report,Safety,Drug Interactions","study_type":"Meta-Analysis","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:53","bibtex":null,"source_record_id":"PMID:41563753","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41563753/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41563753","source_url":"https://pubmed.ncbi.nlm.nih.gov/41563753/","doi":"10.1001/jamanetworkopen.2025.54843","pmid":"41563753","publication_date":"2026-01-02","importer_version":"2.1.3","text_redistributed":false}}],"total":8,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"JAMA network open","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}